the portal vein. The presence and degree of fibrosis depend on parasitic load, immune response and genetic factors. 2 Clinical forms of the disease in humans are classically classified in slight and severe. Persons living in endemic areas usually have the so-called intestinal form or the hepatointestinal form. The later represents an intermediate phase in the evolution of the disease, when a palpable liver can be found at physical examination. Some authors, however, consider that all slight chronic forms of mansoni schistosomiasis are hepatointestinal. In fact, hepatic granumolas around the eggs can be found without evident hepatomegaly. Complains of these patients are scarce and non-specific, as fatigue and diarrhea. Besides Kato's test for the search of eggs in stools, a high percentage of eosinophils in the blood may call the attention for the diagnosis.
About 5% to 10% of infected individuals develop the hepatosplenic form, which gives origin to portal hypertension and is considered the severe form of the disease. As clinical presentation hepatomegaly, specially of the left lobe, and a huge splenomegaly are found. The main manifestation of this severe form is gastrointestinal bleeding due to portal hypertension, leading to high morbidity and mortality. Clinically, what is striking in this type of portal hypertension due to chronic liver disease is the lack of the typical physical signs of hepatic dysfunction as jaundice, spiders, palmar erithema, gynecomastia or ascites. Epidemiological data is very important for the diagnosis since other types of pre-sinusoidal portal hypertension may have a similar clinical presentation, including large splenomegaly. Stool examinations may be repeatedly negative, but abdominal ultrasound, histology of the liver or its angiographic study are usually conclusive for schistosomiasis.
Contrasting with cirrhosis, where fibrosis starts around portal tracts or hepatic veins and spreads forming bridges between hepatic and portal veins, in schistosomiasis the fibrosis is restricted to the portal area, with preservation of the lobular architecture of the liver (Figure 2 ). The macroscopic specimen may show large fibrous septa, the typical "pipestem fibrosis."
In the intra-hepatic vascular tree, the differences between cirrhosis and schistosomiasis are also remarkable. Tortuous vessels are characteristic of cirrhosis whereas the amputation of portal vein branches with formation of multiple thinny vascular channels is consistant with schistosomiasis. "In vivo" angiographic studies detect these differences.
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somiasis is classified as a pre-sinusoidal cause of portal hypertension whereas cirrhosis is typically classified as sinusoidal and post-sinusoidal. It is universally accepted that, regardless the causing disorder or disease, the physiopathologic mechanisms of the syndrome of portal hypertension is basically the same, but there are some differences. 3 The starting point for the elevation of the portal pressure is the increase in vascular resistance and/or an augmentation of blood flow, which gives origin to collateral circulation. This is true for any type of portal hypertension leading to the presence of varices and its consequent bleeding tendency. 4 In the last twenty years we have learned that due to collateral circulation, vasodilating substances reach the systemic circulation creating splanchnic and systemic vasodilation with the consequences of hypervolemia and increased blood flow, closing the vicious cycle of a persistent hypertension in the portal system.
The clinical consequences of portal hypertension, as disease progresses, affect various organs and systems, besides the liver, as kidneys, lungs and brain. In table I consequences of the hyperdinamic circulation in cirrhosis is compared to those found in the same organs or areas for schistosomiasis, where similarities and differences can be found. Usually, some of the clinical manifestations may be related or aggravated by a very poor hepatic function. In schistosomiasis, however, some manifestations are absent or very rare, what has been attributed to a preserved hepatic function.
In a recent review of liver function tests, 5 comparing hepato-intestinal and hepatosplenic forms of schistosomiasis with controls, the authors found slight alterations of liver enzymes: ALT, AST, Alkaline Phosphatase, as well as low platelets and prothrombin time in the hepatosplenic form of the disease. Although albumin levels remain similar to control, other proteins as transthyretin and protein C have shown lower values, attesting a minimal hepatic dysfunction. The altered coagulation test, a constant report in hepatosplenic schistosomiasis is related to hyperesplenism and/or consumption coagulopathy. In conclusion, a direct correlation between portal hypertension and hepatic dysfunction occurs in cirrhosis but not in schistosomiasis ( Figure 3) .
As concomitance of cirrhosis may occur in patients with schistosomiasis, it is essential to differentiate pure forms of hepatosplenic schistosomiasis from the association with the most frequent causes of cirrhosis as alcoholism and hepatitis virus. Hepatitis B has been associated with mansoni schistosomiasis for a long time. 6 Our data, 7 in accordance with others, 8, 9 shows that the infection is more frequent in the hepatosplenic forms associated with bleeding episodes, blood transfusions or other medical manipulations, whereas the earlier forms of schistosomiasis have the same prevalence of HBsAg as control regional groups. A recent work from Pereira and co-authors, 10 shows that in Brazil the more advanced forms of hepatosplenic schistosomiasis, with decompensation, are due to the association with hepatitis C virus.
Jaundice, a symptom of hepatic decompensation is not related to portal hypertension and not found in schistosomiasis. But it may appear after surgical treatment, with predominance of the non-conjugated fraction of bilirubin. Comparing surgeries with and without a shunt procedure, hyperbilirubinemia was present only in those with shunt. Some years ago we have conducted an investigation (Ref) to evaluate the role of splenomegaly or the shunt itself in the production of hemolysis, comparing different groups of patients with presence or absence of these factors. Biochemical parameters: haptoglobin, hemopexin, total and non-conjugated bilirubins were analysed in the 4 groups and compared. The statistical analysis was clear in showing that presence of shunt was the main factor for the development of hemolysis and splenomegaly was only a contributing factor. 11 Hemodynamic studies in schistosomiasis, on the other hand, have shown an important role of splenomegaly. When systemic and hepatic hemodynamics were studied, Brazilian authors 12, 13 have found high cardiac outflow and low periph- Table I . Hyperdynamic circulation is present in portal hypertension due to both cirrhosis and schistosomiasis, but its consequence on systems and organs may be similar or different as depicted here. eral resistance, confirming the existence of a hypercinetic circulation, although cardiac rate and mean arterial pressure remained normal, differently from cirrhosis. As far as hepatic hemodynamics is concerned, besides the very high portal pressure, evaluated by transhepatic measurements, free and wedged venous pressures are usually normal. Differently from cirrhosis, where hepatic blood flow is lower than normal, many authors, including ourselves 14 have described that total hepatic blood flow is normal in portal hypertension due to hepatosplenic schistosomiasis. It has been demonstrated that portal flow remains in the normal range, although splenic flow is extremely high and mesenteric flow is lower than normal. Azygos blood flow is also high, but not as high as the values found in cirrhosis.
Portal hypertension Effects of Hyperdinamic Circulation
Morphological and morphometric studies of intra-hepatic portal veins have shown many telangiectasias ( Figure 4A ), Figure 5 . Blockade doses of propranolol are much higher in patients with portal hypertension due to schistosomiasis than those due to cirrhosis. greater thickness of their muscular layer, as demonstrated in figure 4B and also, although rare, the formation of a type of "varice" of the portal vein ( Figure 4C ). Another important contribution for the diagnosis of Mansoni's hepatosplenic schistosomiasis is abdominal ultrasound. Hyperechoic fibrotic bands can be recongnized along the portal vessels, as well as volumetric reduction of the right hepatic lobe with enlargement of the left one, splenomegaly and peri-vesicular fibrotic thickening. When associated with Doppler features collateral veins and flow abnormalities are also detectable. 15 It is well known that treatment must have a physiopathological basis. If all cases of portal hypertension have a common physiopathological mechanism, efficacy of one type of treatment should be the same for all patients suffering from the syndrome. The efficacy of propranolol, for example, is well demonstrated in cirrhotic patients. 16 But few studies were done in hepatosplenic schistosomiasis, as shown in table II. Hemodynamic studies were initially performed by Lebrec's group 17 who have shown the hyperdiynamic circulation, confirmed in the studies of Mies. 12 We have interrupted a clinical trial comparing propranolol with sclerotherapy due to unfavorable results in the groups taking propranolol, 18 besides the need for very high doses, what may be risky ( Figure 5 ). Although some authors have shown good clinical results, when compared to placebo, long-time follow-up was not available. 19, 20 Other authors confirmed the need for very high doses of propranolol and also showed an increase in the pulmonary venous pressure. 12 In these studies a decrease in portal pressure was not achieved and the decrease of the azigos blood flow was low. These results proned us to avoid the usage of propranolol in Hepatosplenic Schistosomiasis.
For the surgical treatment of portal hypertension portocaval shunt was performed in schistosomiasis in the early sixties but with very bad results. A high percentage of complications were observed, specially hepatic encephalopathy, otherwise not seen in this parasitic disease. Other techniques, as proximal and distal splenorenal shunts were commonly performed in the seventies, whereas a different technical approach, the esophagogastric disconnection with splenectomy was popular in both Egypt and Brazil. 21 We have conducted a randomized clinical trial to study the efficacy of 3 types of surgery namely Proximal Splenorenal Shunt, Distal Splenorenal Shunt and Esophagogastric Disconnection with Splenectomy. 22 After 5 to 10 years of follow-up, with only 9% of dropout, we could show that re-bleeding was the same for the 3 surgical groups, whereas hepatic encephalopathy was greater in the proximal splenorenal shunt, also occurring, after the distal shunt, although some time later (Table III) . But the more striking results were the survival curves, showing that definitely the best option was esophagogastric disconnection with splenectomy 23 ( Figure 6 ). In summary, schistosomiasis is an interesting human model for the study of portal hypertension with minimal hepatic dysfunction. As we have shown, the physiopathological mechanisms seem to have similarities with cirrhosis, but with important differences. Pharmacological therapy showed low efficacy of propranolol besides the need of very high doses. Surgical treatment was the most interesting model to demonstrate that portal hypertension has a different behavior when dissociated from hepatic insufficiency.
